Substance / Medication

Maprotiline

Overview

Active Ingredient
maprotiline
RxNorm CUI
6646

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

59 trials linked to this intervention

59
Total Trials
5
Recruiting
19
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Treatment of double depression: A meta-analysis.
May David G, Shaffer Victoria N, Yoon K Lira · Psychiatry Res · 2020
PMID: 32763535Meta-Analysis
Post-traumatic stress reactions among individuals with visual impairments: a systematic review.
Brunes Audun, Hansen Marianne B, Heir Trond · Disabil Rehabil · 2019
PMID: 29644887Meta-Analysis
Laparoscopic Repair for Perforated Peptic Ulcer Disease Has Better Outcomes Than Open Repair.
Quah Gaik S, Eslick Guy D, Cox Michael R · J Gastrointest Surg · 2019
PMID: 30465190Meta-Analysis
Antidepressants for the treatment of depression in people with cancer.
Ostuzzi Giovanni, Matcham Faith, Dauchy Sarah et al. · Cochrane Database Syst Rev · 2018
PMID: 29683474Meta-AnalysisFull text (PMC)
Prevalence of anxiety and depressive disorders among youth with intellectual disabilities: A systematic review and meta-analysis.
Maïano Christophe, Coutu Sylvain, Tracey Danielle et al. · J Affect Disord · 2018
PMID: 29751238Meta-Analysis
[Comparative observation on efficacy of jieyu pill and maprotiline in treating depression].
Shen Zhen-ming, Zhu Mei-lan, Zhao An-quan · Zhongguo Zhong Xi Yi Jie He Za Zhi · 2004
PMID: 15199625Trial
[A comparative efficiency of amitriptyline, fluoxetine and maprotiline in prevention of migraine in attack-free period].
Amelin A V, Skoromets A A, Korenko L A et al. · Zh Nevrol Psikhiatr Im S S Korsakova · 2000
PMID: 10983362Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Specialists

Providers who commonly manage this intervention

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Maprotiline (substance)
SNOMED CT
387180003
UMLS CUI
C0024778
RxNorm CUI
6646

Clinical Data

This intervention maps to 10 entities in the Ltrl knowledge graph.

5
Conditions
3
Biomarkers
1
Specialists
0
Symptoms
59
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.